Q4 2023 · 13F-HR
GENERAL ATLANTIC, L.P.holdings as filed
Filed 2024-02-13 · accession 0000950142-24-000388
$6.97B
Reported value
26
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 29283F103 | ESMTUSD | ENGAGESMART | $2.07B | 29.7% | 90,271,540 | Common | SOLE |
| G29018101 | DLO | DLOCAL | $1.13B | 16.2% | 63,906,695 | Common | SOLE |
| G98239109 | XP | XP, INC | $772.1M | 11.1% | 29,617,733 | Common | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE | $525.2M | 7.53% | 60,993,323 | Common | SOLE |
| 01644J108 | ALKT | ALKAMI | $454.2M | 6.52% | 18,729,806 | Common | SOLE |
| 433537107 | — | HIRERIGHT | $431.9M | 6.20% | 32,109,898 | Common | SOLE |
| 85225A107 | 8DT | SQUARESPACE | $350.3M | 5.03% | 10,611,073 | Common | SOLE |
| 48576A100 | — | KARUNA THERAPEUTICS | $312.3M | 4.48% | 986,710 | Common | SOLE |
| 29882P106 | EWCZ | EUROPEAN WAX CENTER | $178.2M | 2.56% | 13,110,492 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS | $172.7M | 2.48% | 6,156,252 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS | $77.1M | 1.11% | 9,681,818 | Common | SOLE |
| 44842L103 | HCM | HUTCHMED | $72.4M | 1.04% | 4,000,000 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE | $64.9M | 0.93% | 950,000 | Common | SOLE |
| 60741F104 | MBLY | MOBILEYE | $57.1M | 0.82% | 1,318,782 | Common | SOLE |
| 09352U108 | BLND | BLEND LABS | $48.8M | 0.70% | 19,132,440 | Common | SOLE |
| G7709Q104 | RPRX | ROYALTY PHARMA | $42.1M | 0.60% | 1,500,000 | Common | SOLE |
| 18467V109 | YOU | CLEAR SECURE | $41.9M | 0.60% | 2,028,797 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS | $41.7M | 0.60% | 1,785,714 | Common | SOLE |
| 88427A107 | — | THIRD HARMONIC BIO | $32.5M | 0.47% | 2,958,762 | Common | SOLE |
| 683712103 | OPEN | OPENDOOR | $28.3M | 0.41% | 6,321,519 | Common | SOLE |
| M8216R109 | RSKD | RISKIFIED | $24.9M | 0.36% | 5,324,998 | Common | SOLE |
| 00445A100 | — | ACELYRIN | $21.6M | 0.31% | 2,889,668 | Common | SOLE |
| 36118L106 | FUTU | FUTU | $16.9M | 0.24% | 309,255 | Common | SOLE |
| 21077C305 | 5ZZ0 | WISH | $3.6M | 0.05% | 609,616 | Common | SOLE |
| 39957D201 | GROV | GROVE COLLABORATIVE | $1.7M | 0.02% | 936,020 | Common | SOLE |
| 005329107 | ADAG | ADAGENE | $509,890 | 0.01% | 264,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.